Avicanna to Present at a Life Sciences Investor Forum on September 17, 2026

Avicanna Participates in Virtual Conference OTC Markets Press Release Sept 26

Avicanna Inc. (“Avicanna” or the “Company”), a commercial-stage international biopharmaceutical company focused on cannabinoid-based medicines, is pleased to announce that Aras Azadian, CEO of Avicanna Inc. and Avicanna Inc. will be presenting live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on September 17th, 2026.

Format

PNG

Source

Avicanna Inc.

Downloads